Funding for this research was provided by:
Stockholms Läns Landsting
Åke Wiberg Stiftelse
European Research Council (757919)
Swedish Asthma and Allergy Research Foundation
The Cancer and Allergy Foundation
Received: 31 March 2020
Accepted: 7 May 2020
First Online: 25 May 2020
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee, Karolinska Institutet, Stockholm, and participants gave written informed consent.
: EM has received lecture fees from Novartis, Sanofi and Thermo Fisher Scientific outside the submitted work. MvH has received lecture fees from Thermo Fisher Scientific and ALK; and consultancy fees from Biomay AG, Vienna, Austria and Hycor Biomedical LLC, CA, US, outside the submitted work. Dr. Westman reports personal fees from ALK (consultancy fees), outside the submitted work. The other authors report no competing interests relevant to this article.